Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Sensitive Assay Differentiates Human Papillomavirus

By LabMedica International staff writers
Posted on 28 Jun 2012
A real-time polymerase chain reaction assay detects Human Papillomavirus (HPV) enabling discrimination of all high-risk HPV types in a clinical high-throughput setting. More...


This real-time quantitative polymerase chain reaction assay (qPCR) can be routinely applied in a liquid-based cytology screening setting and can be used in many epidemiological and clinical studies.

Scientists at the University of Antwerp (Belgium) have described the laboratory workflow and the validation of a type-specific qPCR assay for high-throughput HPV detection, genotyping, and quantification. The optimization of each multiplex PCR was based on plasmids for each HPV type and female human DNA. Numerous trials were performed to evaluate the primers, probes, fluorochromes, cycling parameters and the effect of background DNA.

DNA was extracted from cervical cells that had been collected into the ethanol-based preservative Surepath TM (Tripath Imaging; Burlington, NC, USA) using the Cervex-Brush (Rovers Medical Devices B.V.; KV Oss, The Netherlands), and after manipulation, the DNA was amplified in the LightCycler 480 thermocycler (Roche Applied Science; Basel, Switzerland).

The TaqMan-based qPCR assay enables the detection of 17 HPV genotypes and beta-globin in seven multiplex reactions. These HPV types include all 12 high-risk types (HPV16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, and 59), three probably high-risk types (HPV53, 66 and 68), one low-risk type (HPV6) and one undetermined risk type (HPV67). The analytical sensitivity of less than 100 copies was obtained for all the HPV types. The analytical specificity of each primer pair was 100% and an intra- and inter-run variability of less than 6.4% was observed.

Worldwide, cervical cancer is the third most common female cancer. In Western Europe, it is only the 15th most common cause of cancer death in women as a result of cytology-based screening. However, the efficacy of cytological screening is hampered by the high inter-observer variability and high false positive and false-negative rates. The authors concluded that the type-specific real-time PCR approach enables detection of 17 HPV types, identification of the HPV type and determination of the viral load in a single sensitive assay suitable for high-throughput screening. The study was published online on April 5, 2012, in the journal Clinical Chemistry and Laboratory Medicine.

Related Links:

University of Antwerp
Rovers Medical Devices
Roche Applied Science



Gold Member
Troponin T QC
Troponin T Quality Control
Serological Pipet Controller
PIPETBOY GENIUS
New
Automated Microscope
dIFine
New
PlGF Test
Quidel Triage PlGF Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: A simple blood test could replace surgical biopsies for early detecion of heart transplant rejection (Photo courtesy of Shutterstock)

Blood Test Detects Organ Rejection in Heart Transplant Patients

Following a heart transplant, patients are required to undergo surgical biopsies so that physicians can assess the possibility of organ rejection. Rejection happens when the recipient’s immune system identifies... Read more

Pathology

view channel
These images illustrate how precision oncology Organ Chips recapitulate individual patients’ responses to chemotherapy (Photo courtesy of Wyss Institute at Harvard University)

Cancer Chip Accurately Predicts Patient-Specific Chemotherapy Response

Esophageal adenocarcinoma (EAC), one of the two primary types of esophageal cancer, ranks as the sixth leading cause of cancer-related deaths worldwide and currently lacks effective targeted therapies.... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.